Keywords: positive, results, vecura, vroo4, ed, uk-based, vectura

Positive results for Vecura's VRoo4 in ED

Article | 28 July 2003

Print This

UK-based Vectura says it has successfully completed a Phase IIa clinical study for its VR004 (inhaled apomorphine) in the treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in